Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Erythrocyte membrane flexibility refers to the ability of red blood cell (RBC) membranes to deform, bend, and recover their shape as they traverse narrow capillaries and microvasculature. This property is essential for RBCs to efficiently deliver oxygen throughout the body, as it allows them to squeeze through vessels much smaller than their resting diameter. The flexibility enables RBCs’ biconcave shape and allows them to pass through capillaries narrower than their own diameter. Loss or reduction in flexibility impairs microvascular perfusion, reduces tissue oxygenation, and can lead to clinical conditions such as hereditary spherocytosis or sickle cell disease. The interplay between the lipid bilayer’s fluidity and the mechanical properties of the spectrin-actin cytoskeleton determines overall membrane deformability. Damage or mutations affecting any component—lipid composition or cytoskeletal proteins—can reduce flexibility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Erythrocyte Membrane Flexibility.